Sprint Bioscience AB Cash Flow Reinvestment Rate
Sprint Bioscience AB cash flow reinvestment rate. Sprint Bioscience AB (SPRINT) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting Skr105.00K (capex Skr65.00K plus investments Skr40.00K) from operating cash flow of Skr115.84 Million. Explore Sprint Bioscience AB (SPRINT) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sprint Bioscience AB (2015–2025)
Cash flow reinvestment rate of Sprint Bioscience AB from 2015 to 2025. Historical reinvestment intensity for Sprint Bioscience AB across 4 annual periods. Explore SPRINT capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Sprint Bioscience AB Cash Flow Reinvestment Rate by Year (2015–2025)
Sprint Bioscience AB cash flow reinvestment rate by year from 2015 to 2025. Year-by-year capital reinvestment analysis for Sprint Bioscience AB. For the full cash flow conversion analysis, see Sprint Bioscience AB cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr134.00K | Skr83.53 Million | Skr94.00K | ▼ -99.3% |
| 2023 | 0.21x | Skr4.91 Million | Skr22.87 Million | Skr2.45 Million | ▼ -91.4% |
| 2016 | 2.50x | Skr19.82 Million | Skr7.93 Million | Skr9.91 Million | ▼ -66.4% |
| 2015 | 7.43x | Skr6.19 Million | Skr833.54K | Skr6.19 Million | — |